MoneyWorks4Me

The total revenue for the quarter ended December 2023 remained nearly unchanged at Rs. 2880.00 millions.The Net Loss for the quarter ended December 2023 is Rs. -740.00 millions as compared to Net Loss of Rs. -550.00 millions of corresponding quarter ended December 2022The company reported a degrowth in operating Profit to 300.00 millions from 440.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 2880.00 2820.00 2.13 7990.00 7810.00 2.30 10720.00 13720.00 -21.87
Other Income 50.00 180.00 -72.22 170.00 960.00 -82.29 670.00 380.00 76.32
PBIDT 300.00 440.00 -31.82 270.00 1380.00 -80.43 1370.00 2600.00 -47.31
Interest 610.00 520.00 17.31 1780.00 1710.00 4.09 2290.00 2730.00 -16.12
PBDT -310.00 -80.00 287.50 -1650.00 -830.00 98.80 -3270.00 -130.00 2415.38
Depreciation 430.00 470.00 -8.51 1310.00 1410.00 -7.09 1860.00 1710.00 8.77
PBT -740.00 -550.00 34.55 -2960.00 -2240.00 32.14 -5130.00 -1840.00 178.80
TAX 0.00 0.00 0.00 0.00 -570.00 0.00 -470.00 -440.00 6.82
Deferred Tax 0.00 0.00 0.00 0.00 -570.00 0.00 -470.00 -490.00 -4.08
PAT -740.00 -550.00 34.55 -2960.00 -1670.00 77.25 -4660.00 -1400.00 232.86
Equity 720.00 720.00 0.00 720.00 720.00 0.00 720.00 720.00 0.00
PBIDTM(%) 10.42 15.60 -33.24 3.38 17.67 -80.88 12.78 18.95 -32.56
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..